Status | Study |
Completed |
Study Name: Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients Condition: Cytomegalovirus Infections Date: 2012-06-01 Interventions: Drug: Maribavir Tablet for oral administration |
Recruiting |
Study Name: Evaluation of the PK and PD of Ganciclovir in Premature Infants Receiving Treatment for CMV Infection Condition: Cytomegalovirus Infections Date: 2012-05-17 |
Completed |
Study Name: Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection Condition: Cytomegalovirus Disease Date: 2012-01-10 Interventions: Drug: Valganciclovir Valcyte p |
Completed |
Study Name: Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants Condition: Cytomegalovirus Infection Preterm Infants Date: 2010-07-26 Interventions: Procedure: ultrashort heat inactivation |
Completed |
Study Name: Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection Condition: Cytomegalovirus Infection Date: 2009-04-14 Interventions: Drug: HCMV-specific hyperimmune globulin (Cytotect®) |
Recruiting |
Study Name: Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients Condition: Cytomegalovirus Disease Date: 2009-01-23 Interventions: Drug: Certican (everolimus) + valganciclovir |
Completed |
Study Name: Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients Condition: Cytomegalovirus Infection Date: 2008-10-15 |
Completed |
Study Name: Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients Condition: Cytomegalovirus Infection Date: 2008-08-05 Interventions: Drug: Single arm (ganciclovir and valganciclovir) Patients received a short induction of IV ganciclovir |
Completed |
Study Name: Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections Condition: Cytomegalovirus Infection Date: 2007-04-26 Interventions: Other: Placebo 9 grams of powd |
Completed |
Study Name: IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients Condition: Cytomegalovirus Infections Date: 2006-02-21 Interventions: Drug: Valganciclovir 900 mg or |